Gly-Arg-Cys(&)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(&)-Phe-Pro-Asp | 368879-60-1

——

——

Gly-Arg-Cys(&)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(&)-Phe-Pro-Asp

Gly-D-Arg-cyclo-[Cys-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys]-Phe-Pro-Asp；SFTI-1-(1,14)-peptide；1JBN；H-Gly-Arg-Cys(1)-Thr-Lys-Ser-Ile-Pro-Pro-Ile-Cys(1)-Phe-Pro-Asp-OH；(2S)-2-[[(2S)-1-[(2S)-2-[[(3S,9S,12S,15S,18S,21R,26R,29S,32S)-21-[[(2S)-2-[(2-aminoacetyl)amino]-5-(diaminomethylideneamino)pentanoyl]amino]-15-(4-aminobutyl)-9,29-bis[(2S)-butan-2-yl]-18-[(1R)-1-hydroxyethyl]-12-(hydroxymethyl)-2,8,11,14,17,20,28,31-octaoxo-23,24-dithia-1,7,10,13,16,19,27,30-octazatricyclo[30.3.0.03,7]pentatriacontane-26-carbonyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]butanedioic acid